ACR 2022 | COVID-19 vaccination advocated for pregnant women with RMDs

By FYH News Team

Published on November 15, 2022

[ad_1]

medwireNews: Vaccination against COVID-19 should be actively promoted for women with rheumatic and musculoskeletal diseases (RMDs) who are pregnant or planning a pregnancy, researchers say.

Their findings, presented on a poster at ACR Convergence 2022 in Philadelphia, Pennsylvania, USA, showed a higher rate of preterm birth in 47 unvaccinated or partially vaccinated (one dose) women with RMD who developed COVID-19 during their pregnancy than 26 comparable women. women who were fully vaccinated (two or more doses), by 29.5% versus 18.2%. However, the difference between the groups did not reach statistical significance.

The most common RMDs were systemic lupus erythematosus (23%) and rheumatoid arthritis (21.9%) and the majority (70%) of patients were in remission when diagnosed with COVID-19.

At the time of data extraction, there were 55 completed pregnancies, of which 50 were live births. The most common neonatal complication was low birth weight (

Most women were not vaccinated when they were diagnosed with COVID-19, while 4% were partially vaccinated and 36% were fully vaccinated.

Hospitalization was necessary for 21% of women regardless of vaccination status, but only 16% required COVID-19-specific medication.

“This would mean that the severity of COVID-19 was comparable between vaccinated and partially vaccinated or unvaccinated women,” said Sinead Maguire (St James’ Hospital, Dublin, Ireland) in a press release. “This was an unexpected result, given the differences in obstetric and neonatal outcomes.”

November 15, 2022: The coronavirus pandemic affects all healthcare professionals around the world. During this difficult time, Medicine Matters’ focus is on disseminating the latest data to support you in your research and clinical practice, based on the scientific literature. We will update the information we provide on the site as the data is published. However, please refer to your own professional and government guidelines for the most current guidelines in your own country.

ACR convergence 2022; Philadelphia, Pennsylvania, US: November 10-14

[ad_2]

Source link

Features

Download and distribute powerful vaccination QI resources for your community.

MCED tests use a simple blood draw to screen for many kinds of cancer at once.

FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.

Discover an honest look at our Medicare system.

ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.